<DOC>
	<DOCNO>NCT02690870</DOCNO>
	<brief_summary>The purpose prospective cohort study compare IVF outcome tamoxifen clomiphene citrate mild stimulation .</brief_summary>
	<brief_title>Tamoxifen Clomiphene Citrate Mild Stimulation IVF</brief_title>
	<detailed_description>The report prevalence poor ovarian responder amongst patient undergo IVF-ET 9 % -24 % , morbidity must high nowadays . For woman , Mild stimulation important ovulation induction protocol . Clomiphene citrate ( CC ) tamoxifen ( TMX ) commonly use mild stimulation protocol . It 's report CC adverse effect growth endrometrium result thin endrometrium ( ≤7mm ) maybe affect pregnancy rate . However , TMX estrogen-like effect endrometrium may helpful increase endormetrial thickness . The reported result compare CC TMX show similar ovulation rate . Prospective study necessary confirm whether TMX superior CC IVF outcome .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1. age 37 42 ; 2 . BMI≤23kg/m2 ; 3 . ≤3 oocytes conventional stimulation protocol ; 4 . AFC＜5 follicles AMH＜1.1 ng/ml day 1 5 menses ; 5 . Cause Infertiity : tubal factor , male factor , diminish ovarian reserve . 1. endormetrial polyp , endormetrial cancer , intrauterine adhesion , uterine fibroid affect uterine cavity 2 . Endometriosis , adenomyosis 3 . The diameter Hydrosalpinx ＞2cm</criteria>
	<gender>Female</gender>
	<minimum_age>37 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>tamoxifen</keyword>
	<keyword>clomiphene</keyword>
	<keyword>mild stimulation</keyword>
	<keyword>poor ovarian response</keyword>
	<keyword>clinical pregnancy rate</keyword>
</DOC>